ID
38666
Beskrivning
Study ID: 106837 Clinical Study ID: HZA106837 Study Title: A Long-Term, Randomized, Double-Blind, Parallel Group Study of Fluticasone Furoate/GW642444 Inhalation Powder Once-Daily and Fluticasone Furoate Inhalation Powder Once-Daily in Subjects with Asthma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01086384 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol Trade Name: Relvar Study Indication: Asthma
Nyckelord
Versioner (4)
- 2018-11-05 2018-11-05 -
- 2018-11-05 2018-11-05 -
- 2018-12-04 2018-12-04 -
- 2019-10-30 2019-10-30 - Sarah Riepenhausen
Rättsinnehavare
GSK group of companies
Uppladdad den
30 oktober 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
A Parallel Group Study of Fluticasone Furoate/Vilanterol in Subjects with Asthma - 106837
Concomitant Medications Form
- StudyEvent: ODM
Similar models
Concomitant Medications Form
- StudyEvent: ODM
C1522508 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0947323 (UMLS CUI [1,2])
C0033080 (UMLS CUI [1,2])
C0013231 (UMLS CUI [2])
C0808070 (UMLS CUI [1,2])
C2603343 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2])
C0439810 (UMLS CUI [1,2])
C0349790 (UMLS CUI [1,2])
C0884980 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Inga kommentarer